Back

Soy Isoflavones

alleviating menopausal symptoms

Evidence · Grade B
Meta-analysis availableSystematic review availableHuman trial evidenceTraditional useInteraction risk

Plant-based estrogens for menopausal symptoms

Soy isoflavones (genistein and daidzein) are phytoestrogens that bind to estrogen receptors and may exert mild estrogenic or anti-estrogenic effects, potentially reducing hot flash frequency and severity.

Quick answer

What it is: Soy isoflavones (genistein and daidzein) are phytoestrogens that bind to estrogen receptors and may exert mild estrogenic or anti-estrogenic effects, potentially reducing hot flash frequency and severity.

May support:Perimenopause, Menopause

Evidence:Evidence · Grade B

Evidence Summary

Evidence · Grade B

The current understanding of soy isoflavones' efficacy is largely based on a substantial body of observational studies, in vitro research, and some clinical trials. However, without specific PubMed studies provided for this request, a definitive evidence grade cannot be assigned. General knowledge suggests that while many studies exist, their quality and consistency vary, leading to mixed conclusions regarding their effectiveness for specific conditions.

Last reviewed · Jun 2026

Have you tried Soy Isoflavones?

Vote in 5 seconds. Add details if you want.

Your experience for Perimenopause:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Soy Isoflavones

Search on Reddit →

Latest News

Latest news on Soy Isoflavones

More on Google News →

Health Videos

Health videos on Soy Isoflavones

More on YouTube

Why It Works

Soy isoflavones act as phytoestrogens, binding to estrogen receptors (ERs) in the body, which can modulate estrogenic activity, potentially influencing hormonal balance.

How it works in more detail

Soy isoflavones, primarily genistein and daidzein, are structurally similar to 17β-estradiol and can bind to both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ). They generally exhibit a higher affinity for ERβ than for ERα. By binding to these receptors, isoflavones can exert weak estrogenic or anti-estrogenic effects, depending on the tissue, the endogenous estrogen levels, and the specific isoflavone. This selective estrogen receptor modulator (SERM)-like activity is thought to contribute to their potential effects on menopausal symptoms, bone density, and cardiovascular health. Furthermore, daidzein can be metabolized by gut bacteria into equol, which has a higher estrogenic potency and antioxidant activity than its precursor. The presence and activity of equol-producing bacteria vary significantly among individuals, influencing the overall bioavailability and efficacy of soy isoflavones.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
Common consumer dosages for soy isoflavone supplements typically range from 50 mg to 100 mg of total isoflavones per day, often taken in capsule or tablet form. This dosage is generally derived from amounts found in traditional Asian diets.
Research dosage range
Clinical studies have utilized a wide range of soy isoflavone dosages, often between 40 mg and 150 mg of total isoflavones daily, with some studies exploring higher doses for specific outcomes.
Typical onset
The effects of soy isoflavones, particularly for menopausal symptoms, may not be immediate and can take several weeks to months of consistent use to become noticeable.
Typical forms
Capsule, Tablet, Powder, Food (tofu, tempeh, miso)
Quality markers
When selecting soy isoflavone supplements, look for products that specify the amount of total isoflavones (genistein, daidzein, glycitein) per serving. Third-party testing for purity and potency can help ensure product quality. Opt for non-GMO soy sources if preferred.
Medication interactions
  • Tamoxifen (potential reduction in efficacy)
  • Warfarin (potential to alter blood clotting)
  • Thyroid hormones (potential to interfere with absorption or efficacy)
  • Oral contraceptives (potential to alter efficacy)
Avoid if
  • Estrogen-sensitive cancers (e.g., breast cancer, ovarian cancer)
  • Thyroid disorders (potential interaction with thyroid hormones)
  • Allergy to soy

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

Common consumer dosages for soy isoflavone supplements typically range from 50 mg to 100 mg of total isoflavones per day, often taken in capsule or tablet form. This dosage is generally derived from amounts found in traditional Asian diets.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Genistein, Daidzein, Glycitein, Equol (a metabolite of daidzein)

Traditional use

Soy has been a staple food in Asian diets for thousands of years, consumed in various forms such as tofu, tempeh, miso, and soy milk. Traditional use is primarily as a food source, with observations of lower rates of certain chronic diseases and menopausal symptoms in populations with high soy intake.

Safety

Safety warnings

Soy isoflavones are generally considered safe when consumed as part of a typical diet. However, in supplement form, potential concerns include interactions with certain medications and hormonal conditions. Individuals with a history of estrogen-sensitive cancers or those undergoing hormone replacement therapy should consult a healthcare professional before using soy isoflavone supplements. Long-term safety data for high-dose supplementation is still being evaluated.

Avoid if

  • Estrogen-sensitive cancers (e.g., breast cancer, ovarian cancer)
  • Thyroid disorders (potential interaction with thyroid hormones)
  • Allergy to soy

Medication interactions

  • Tamoxifen (potential reduction in efficacy)
  • Warfarin (potential to alter blood clotting)
  • Thyroid hormones (potential to interfere with absorption or efficacy)
  • Oral contraceptives (potential to alter efficacy)

Reported side effects

  • Mild gastrointestinal upset
  • Bloating
  • Constipation

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (B)

The current understanding of soy isoflavones' efficacy is largely based on a substantial body of observational studies, in vitro research, and some clinical trials. However, without specific PubMed studies provided for this request, a definitive evidence grade cannot be assigned. General knowledge suggests that while many studies exist, their quality and consistency vary, leading to mixed conclusions regarding their effectiveness for specific conditions.

Filter by source type

Meta-Analyses(1)

Pooled analyses across multiple human trials.

Very High Quality
  • The effectiveness of nutritional supplements in improving polycystic ovary syndrome in women: a systematic review and network meta-analysis.

    Zhao G, Fan Y, Li R, Huang Y, Li W, Zhao Y · Reproductive biology and endocrinology : RB&E · 2025 · n=501

    Nutritional supplements are known to ameliorate polycystic ovary syndrome (PCOS) and have been shown to modulate endocrine and metabolic markers, oxidative stress markers and inflammatory biomarkers in patients with PCOS. A variety of nutritional supplements have been applied in clinics, but a more comprehensive ranking of their efficacy has not yet been investigated. To assess the comparative effectiveness of nutritional supplements in women with PCOS. A systematic search was conducted across PubMed, EMBASE, Web of Science, and the Cochrane Library for randomized controlled trials (RCTs) that met the inclusion criteria up to October 12, 2023. We performed a network meta-analysis (NMA) to evaluate the effectiveness of various nutritional supplements on different indicators of PCOS by synthesizing both direct and indirect evidence from the trials. Seventy-nine RCTs involving 5,501 participants were enrolled in the NMA. It suggested that chromium was notably effective in improving fol

    Meta-AnalysisPubMedVery High Quality

Systematic Reviews(1)

Structured reviews of the full body of evidence (incl. Cochrane).

Very High Quality
  • Effect of nutritional interventions on the psychological symptoms of premenstrual syndrome in women of reproductive age: a systematic review of randomized controlled trials.

    Robinson J, Ferreira A, Iacovou M, Kellow NJ · Nutrition reviews · 2025 · n=3254

    Premenstrual syndrome (PMS) affects approximately 48% of women of reproductive age worldwide. It can lead to functional impairment, lower quality of life, and decreased work productivity. Despite the availability of medical treatment options, women are seeking alternative interventions because of concerns of harmful side effects and limited evidence of efficacy associated with pharmacological treatments. To date, high-quality research investigating the effects of dietary and nutrient intervention on PMS is limited. This systematic review investigated the effect of nutritional interventions on the psychological symptoms of PMS. Five electronic databases were searched for randomized controlled trials (RCTs) published in English from inception to October 2022. Trials eligible for inclusion were nutritional intervention studies involving women of reproductive age that measured PMS-associated psychological outcomes. Articles were selected using prespecified inclusion criteria. Data scree

    Systematic ReviewPubMedVery High Quality

Randomized Human Trials(1)

Controlled human studies with random assignment.

High Quality
  • Assessing the combined effects of Black Cohosh, Soy Isoflavones, and SDG Lignans on menopausal symptoms: a randomized, double-blind, placebo-controlled clinical trial.

    Pokushalov E, Ponomarenko A, Garcia C, Kasimova L, Pak I, Shrainer E · European journal of nutrition · 2025 · n=90

    This randomized, double-blind, parallel-group clinical trial aimed to evaluate the efficacy of Black Cohosh, Soy Isoflavones, and SDG Lignans in alleviating menopausal symptoms compared to a placebo. Ninety-six postmenopausal women aged 45-60 years were enrolled. Participants were randomized to receive either the study supplements or a placebo for 90 days, with Menopause Rating Scale (MRS) scores collected at baseline and every 4 weeks to monitor symptom changes. Secondary outcomes assessed included hormonal variations and the incidence of adverse symptoms. Of the initial cohort, 90 participants completed the study with high adherence. Significant improvements were observed in the treatment group across all MRS domains: somatic (- 54.3% difference, p < 0.01), psychological (- 54.3% difference, p < 0.01), urogenital (-37.3% difference, p < 0.01), and total score (- 48.0% difference, p < 0

    Randomized TrialPubMedHigh Quality

Observational Studies(1)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality
  • The role of diet in managing menopausal symptoms: A narrative review.

    Yelland S, Steenson S, Creedon A, Stanner S · Nutrition bulletin · 2023

    Menopause is a natural stage that occurs when women stop menstruating, during which many women experience physical and psychological symptoms that can affect their quality of life and ability to work. Dietary modifications and food supplements may be explored by some women as alternatives to hormone replacement therapy, although existing reviews and expert position statements have given this limited consideration. This narrative review summarises the current evidence for dietary patterns, and botanical and food supplements, in the management of common menopausal symptoms, including vasomotor symptoms (VMS; hot flushes; night sweats), changes in bodyweight and composition, psychological symptoms (depression; anxiety; cognitive changes), sleep disturbances, joint pain, skin changes and urogenital symptoms. Soy isoflavones may reduce the frequency and/or severity of VMS, although results are inconsistent, and it is unclear whether dietary and supplemental sources have comparable effects.

    Observational StudyPubMedLow Quality

Clinical Trial Registries(1)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • Phase I Multiple-Dose Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women

    n=36 · NCT00491595 · COMPLETED · COMPLETED

    The purpose of this research study is to examine the safety of specific soy components, known as isoflavones, and to find out what effects (good and bad) these components have on tissues that are sensitive to the hormone estrogen in healthy, post-menopausal women. Isoflavones are compounds that occur naturally in soybeans and can be extracted to put in to capsule form or add to foods. The capsule formulation being used in this study is considered an investigational drug. This research is being done because many scientists believe that isoflavones may play a role in the prevention of some kinds of cancer. While isoflavones have been safely consumed in foods for centuries, we need to know if these soy components are safe to take in higher doses when they are extracted from foods and provided in a supplement form. We plan to test the safety and effects of the soy isoflavones known as genistein, daidzein and glycitein.

    Clinical TrialClinicalTrials.govModerate Quality

Limitations: A significant limitation in the research on soy isoflavones is the variability in study design, dosages used, duration of intervention, and the specific populations studied. Differences in gut microbiota, which affect the metabolism of isoflavones into more active compounds like equol, can also lead to inconsistent results. Furthermore, many studies are small or have methodological limitations, making it challenging to draw broad conclusions. The lack of specific PubMed studies for this request prevents a detailed analysis of current evidence gaps.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Soy Isoflavones?

Help others see what actually works.